According to Spectrum Pharmaceuticals
's latest financial reports the company has $26.8 M in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2022-12-31 | $27.88 M | -41.35% |
2021-12-31 | $47.55 M | -64.58% |
2020-12-31 | $0.13 B | -29.49% |
2019-12-31 | $0.19 B | -32.79% |
2018-12-31 | $0.28 B | -19.38% |
2017-12-31 | $0.35 B | 48.86% |
2016-12-31 | $0.23 B | 10.88% |
2015-12-31 | $0.21 B | -16.38% |
2014-12-31 | $0.25 B | -9.61% |
2013-12-31 | $0.28 B | -1.14% |
2012-12-31 | $0.28 B | 51.59% |
2011-12-31 | $0.18 B | 152.31% |
2010-12-31 | $74.47 M | -31.25% |
2009-12-31 | $0.10 B | 101.04% |
2008-12-31 | $53.88 M | 10.53% |
2007-12-31 | $48.74 M | 6.33% |
2006-12-31 | $45.84 M | -24.85% |
2005-12-31 | $61 M | 60.91% |
2004-12-31 | $37.91 M | 56.15% |
2003-12-31 | $24.28 M | 3511.35% |
2002-12-31 | $0.67 M | -90.09% |
2001-12-31 | $6.78 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $70.02 B | 261,119.92% | ๐บ๐ธ USA |
Novartis NVS | $39.75 B | 148,215.61% | ๐จ๐ญ Switzerland |
Pfizer PFE | $92.55 B | 345,201.25% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $39.04 B | 145,555.66% | ๐บ๐ธ USA |
Biogen BIIB | $15.21 B | 56,654.34% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $16.54 B | 61,634.75% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $16.71 B | 62,268.21% | ๐ฌ๐ง UK |
Seagen
SGEN | $2.55 B | 9,414.72% | ๐บ๐ธ USA |
Curis CRIS | $9.46 M | -64.70% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $7.54 B | 28,040.27% | ๐ฎ๐ฑ Israel |